Industries > Pharma > Antiviral Drugs Treatment Market Report 2021-2031
Antiviral Drugs Treatment Market Report 2021-2031
Forecasts by Drug Class (Reverse Transcriptase Inhibitors, Protease Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Others), by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antiviral Drugs Companies AND COVID-19 Recovery Scenarios
Antiviral Drugs Treatment Market – reveals latest trends, opportunities, predicted revenues, and competitive analysis. Read on to determine how you can exploit the impending business opportunities emerging in this sector along with detailed COVID-19 recovery scenarios.
Global antiviral drugs treatment market is projected to reach at a market value of US$xx billion by 2031 with a lucrative CAGR during the forecast period. The growing prevalence of viral diseases including HIV, influenza, herpes, hepatitis and other viral is a major factor that drives the demand for antiviral drugs treatment. Other key drivers boosting the market growth are increasing geriatric population; advancement in anti-viral drugs R&D; rising strategic initiatives for anti-viral drugs market and developing healthcare infrastructure in emerging economies. Additionally, the COVID-19 pandemic has a significant impact on the antiviral drugs treatment market. Thus, the demand for antiviral drugs treatment is expected to rise during the forecast period.
Visiongain’s report shows you the potential revenues streams to 2031, assessing the different segments, major players, qualitative analysis, opportunities trends, and business prospects in the antiviral drugs treatment industry.
How this report will benefit you
Visiongain’s new study is envisioned for anyone requiring commercial in-depth analyses for the global antiviral drugs treatment market along with detailed segment analysis in the market. Our new study assists you to evaluate the overall global and regional market for antiviral drugs treatment. Get the financial analysis of the overall market and different segments including by drug class, route of administration, usability, and distribution channel. High opportunity remains in this fast-growing antiviral drugs treatment market. See how to use the existing and upcoming opportunities in this market to gain revenue benefit in the near future. Moreover, the report would help you to improve your strategic decision making, allows you to frame growth strategies, reinforce the analysis of other market players, and maximise productivity of the company.
Forecasts to 2031 and other analyses reveal the commercial prospects
• Our new study provides you with revenue forecast by different segments including drug class, application, and end user to 2031
• It also includes growth rates for different 5 regional markets along with 18 countries and COVID-19 impact analysis on each market
• The profiles of the top 12 companies are very descriptive and comprehensive data including company snapshot, overview, commercial developments, company market shares, and detailed financial analysis with revenue and other financials
• The COVID-19 has a positive impact on the antiviral drugs treatment industry and the report includes detailed analysis and invaluable insight into how COVID-19 will affect the industry.
To access the data contained in this document please email contactus@visiongain.com
Discover sales forecasts for the global and regional market forecasts from 2021-2031
Along with revenue prediction for the overall global market, there is segmentation by region for 5 regional markets including North America, Europe, Asia Pacific, Latin America, and MEA and 20 major countries.
Global Antiviral Drugs Treatment Market Revenue and Growth Forecasts from 2021 to 2031 By Drug Class
• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• DNA Polymerase Inhibitors
• Neuraminidase Inhibitors
• Others
Global Antiviral Drugs Treatment Market Revenue and Growth Forecasts from 2021 to 2031 By Application
• Hepatitis
• HIV
• Influenza
• Herpes
• Others
Global Antiviral Drugs Treatment Market Revenue and Growth Forecasts from 2021 to 2031 By End User
• Hospitals
• Clinics
• Others
Regional market revenue and growth forecasts from 2021 to 2031:
• North America
– U.S.
– Canada
• Europe
– Germany
– UK
– France
– Italy
– Spain
– Russia
– Rest of Europe
• Asia Pacific
– Japan
– China
– India
– Australia
– South Korea
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Rest of Latin America
• Middle East and Africa
– South Africa
– GCC
– Rest of MEA
Need industry data? Please contact us today.
Detailed profiles of 12 leading companies that are operating in the market
The report includes profiles of 12 major companies involved in the antiviral drugs treatment market. The companies profiled in this report include:
AbbVie, Cipla, Gilead Sciences, GlaxoSmithKline (GSK), Novartis, F. Hoffmann-La Roche Ltd, Boehringer Ingelheim Corporation, AstraZeneca AB, Johnson & Johnson, Merck & Co, Bristol-Myers-Squibb and Abbott Laboratories.
Find qualitative and quantitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
In summary, our 460+ page report delivers you with the following knowledge:
• Revenue forecasts from 2021 to 2031 for the global antiviral drugs treatment market and subsegments (by drug class, indication, distribution channel, and region)– discover the industry’s prospects, finding the most lucrative areas for investments and revenue generation
• Detailed profiles of top 12 antiviral drugs treatment manufacturers, with financial overviews for net revenues, operating income, R&D investment, and segment revenues
• Revenue forecasts from 2021 to 2031 for 5 regional markets – See forecasts for the antiviral drugs treatment market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Information found nowhere else
With this new and exclusive report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your investment, research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the antiviral drugs treatment market and detailed analysis of COVID-19 impact. You will get the most recent data, opportunities, trends, and predictions.
The Antiviral Drugs Treatment Market Report 2021-2031 will be of value to anyone who wants to better understand the market and its various segments. It would be valuable for companies that desire to better understand the part of the industry they are involved in, or those coveting to expand or enter into a different regional market or to understand strategic analysis of leading companies of the antiviral drugs treatment industry.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Antiviral Drugs Treatment Market Report 2021-2031: Forecasts by Drug Class (Reverse Transcriptase Inhibitors, Protease Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Others), by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antiviral Drugs Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Antiviral Drugs Treatment Market
1.2 Antiviral Drugs Treatment Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Increasing Incidence of Viral Diseases to drive market growth
3.1.2 Increasing Geriatric Population is projected to propel the Demand for Anti-Viral Drugs
3.1.3 Advancement in Anti-Viral Drugs R&D is driving the Market Growth
3.1.4 Rising Strategic Initiatives for Anti-Viral Drugs Market is another Major Factor Propelling the Market Growth
3.2 Restraints
3.2.1 Stringent Regulations Associated with Product Approval Hinders the Market Growth
3.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.3 Rising Prevalent Resistance to Neuraminidase Inhibitors
3.3 Opportunities
3.3.1 Increasing Corona Virus Disease Emerge Need for Anti-Viral Drugs
3.3.2 M&A and Collaboration by the leading Vendors Provide Opportunity to Grow in the Market
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: Moderate
3.4.5 Threat of Substitutes: Moderate
3.5 PEST Analysis
3.5.1 Political Factors Impacting Antiviral Drugs Treatment Market
3.5.2 Economic Factors Impacting Anti-Viral Drugs Market
3.5.3 Social Factors Impacting Anti-Viral Drugs Market
3.5.4 Technological Factors Impacting Anti-Viral Drugs Market
4 Antiviral Drugs Treatment Market by Drug Class Forecast, 2021-2031
4.1 Reverse Transcriptase Inhibitors Segment Market Forecast, 2021-2031
4.1.1 The reverse-transcriptase inhibitors are class of antiretroviral drugs, majorly used to treat HIV infection and Hepatitis B
4.1.2 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.2 Protease Inhibitors Segment Market Forecast, 2021-2031
4.2.1 The Antiretroviral protease inhibitors bind the catalytic site of the HIV protease
4.2.2 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.3 DNA Polymerase Inhibitors Segment Market Forecast, 2021-2031
4.3.1 Inhibiting DNA synthesis is significant therapeutic strategy, widely used to treat the viral infections
4.3.2 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.4 Neuraminidase Transcriptase Inhibitors Segment Market Forecast, 2021-2031
4.4.1 Growing Public awareness, boost in the Research and Development segment swelling interest to support the development of new Antiviral drugs
4.4.2 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.5 Others Segment Market Forecast, 2021-2031
4.5.1 Other Essential Inhibitors
4.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5 Antiviral Drugs Treatment Market by Application Forecast, 2021-2031
5.1 Hepatitis Segment Market Forecast, 2021-2031
5.1.1 Largest Revenue Grossing Segment / Hepatitis C Virus (HCV) is transmitted through infective blood exposure, or by HCV contaminated blood and blood products
5.1.2 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.2 HIV Segment Market Forecast, 2021-2031
5.2.1 HIV needs protease to replicate, which includes atazanavir, darunavir, fosamprenavir, and lopinavir
5.2.2 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.3 Influenza Inhibitors Segment Market Forecast, 2021-2031
5.3.1 The neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir and peramivir) and M2 protein inhibitors are class of antiviral drugs to treat viral infection
5.3.2 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.4 Herpes Segment Market Forecast, 2021-2031
5.4.1 Herpes is caused by Herpes simplex virus (HSV), which develops sores or blisters to form in or around the mouth or genitals
5.4.2 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.5 Others Segment Market Forecast, 2021-2031
5.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Segment Growth
5.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6 Antiviral Drugs Treatment Market by End User Forecast, 2021-2031
6.1 Hospital Segment Market Forecast, 2021-2031
6.1.1 Pandemic emerge the demand for antiviral drugs
6.1.2 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.2 Clinics Segment Market Forecast, 2021-2031
6.2.1 Increasing use of antiviral drugs for primary treatment include hepatitis B, herpes virus and Influenza virus
6.2.2 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast 2021-2031: Recovery Scenarios (V, U, W, L)
6.3 Others Segment Market Forecast, 2021-2031
6.3.1 The Research Institutes Specialize in the Field of Viral Infection
6.3.2 Recovery Scenarios (V, U, W, L)
7 Global Antiviral Drugs Treatment Market Regional Forecast, 2021-2031
7.1 Global Antiviral Drugs Treatment Market by Region Forecast 2021-2031
7.2 Global Antiviral Drugs Treatment Market Forecast by Region: Recovery Scenarios (V, U, W, L)
8 North America Antiviral Drugs Treatment Market, 2021-2031
8.1 Largest Market Share acquired by North America in Global Antiviral Drugs Treatment Market
8.2 North America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
8.3 North America Antiviral Drugs Treatment Market Forecast by Drug Class
8.3.1 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
8.4 North America Antiviral Drugs Treatment Market Forecast by Application
8.4.1 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
8.5 North America Antiviral Drugs Treatment Market Forecast by End User
8.5.1 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
8.6 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031
8.6.1 Growing burden of Viral Diseases such as HIV, Hepatitis and Corona virus
8.6.2 Presence of Highly Developed Healthcare Infrastructure
8.6.3 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
8.7 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031
8.7.1 Growing burden of Viral Diseases and Government support
8.7.2 Benefits of manufacturing and R&D Operations in Canada
8.7.3 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9 Europe Antiviral Drugs Treatment Market, 2021-2031
9.1 Increasing aging population worldwide would have a direct impact on the healthcare systems,
9.2 Europe Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
9.3 Europe Antiviral Drugs Treatment Market Forecast by Drug Class
9.3.1 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
9.4 Europe Antiviral Drugs Treatment Market Forecast by Application
9.4.1 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
9.5 Europe Antiviral Drugs Treatment Market Forecast by End User
9.5.1 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
9.6 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031
9.6.1 Strong Research and Development pipelines coupled with increasing product launches by the major players
9.6.2 Hepatitis A outbreaks in European Region and the Americas
9.6.3 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.7 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031
9.7.1 Growing HIV Infection
9.7.2 Growing ageing population creating challenges
9.7.3 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.8 France Antiviral Drugs Treatment Market Forecast, 2021-2031
9.8.1 Growing old age population
9.8.2 Affordable Healthcare Services with Workforce Flexibility
9.8.3 France Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.9 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031
9.9.1 Growing Pharmaceutical Industry
9.9.2 Italy ranks amongst the countries with the maximum life expectancy worldwide
9.9.3 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.10 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031
9.10.1 Strongest Economy with growing pharmaceutical Industry
9.10.2 Spreading HIV in the country
9.10.3 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.11 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031
9.11.1 Promising Russian Pharmaceutical Industry
9.11.2 Unmet Pharmaceutical Needs
9.11.3 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031
9.12.1 Growing prevalence of viral infections and strategic initiatives by major market players
9.12.2 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10 Asia Pacific Antiviral Drugs Treatment Market, 2021-2031
10.1 Increased funding for HIV in developing countries
10.2 Asia Pacific Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
10.3 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class
10.3.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
10.4 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application
10.4.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
10.5 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User
10.5.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
10.6 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031
10.6.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
10.6.2 Government Initiative
10.6.3 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.7 China Antiviral Drugs Treatment Market Forecast, 2021-2031
10.7.1 Strategic initiatives taken by market Player
10.7.2 Increasing Healthcare Spending
10.7.3 China Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.8 India Antiviral Drugs Treatment Market Forecast, 2021-2031
10.8.1 India has the third largest HIV epidemic in the world
10.8.2 Developing Healthcare Infrastructure
10.8.3 India Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.9 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031
10.9.1 Government Programme Expand Access to Quality Healthcare
10.9.2 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.10 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031
10.10.1 Spreading HIV in South Korea Region
10.10.2 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.11 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031
10.11.1 Growing viral infection in this Region
10.11.2 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11 Latin America Antiviral Drugs Treatment Market, 2021-2031
11.1 Growing Geriatric population as well as growing GDP of this region
11.2 Latin America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
11.3 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class
11.3.1 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
11.4 Latin America Antiviral Drugs Treatment Market Forecast by Application
11.4.1 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 Latin America Antiviral Drugs Treatment Market Forecast by End User
11.5.1 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031
11.6.1 Growing burden of Viral Disease in Brazil
11.6.2 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11.7 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
11.7.1 Growing Pharmaceutical Industry in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
11.8 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031
11.8.1 Evolving Healthcare Infrastructure
11.8.2 Government and Major market player investing in this region
11.8.3 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12 Middle East and Asia Antiviral Drugs Treatment Market, 2021-2031
12.1 Middle East and Africa Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
12.2 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class
12.2.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
12.3 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application
12.3.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User
12.4.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.5 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031
12.5.1 South Africa ranks 3rd of all new HIV Infection in Southern Africa region
12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
12.5.3 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031
12.6.1 Developing Healthcare Industry in this region
12.6.2 Presence of Huge Growth Opportunities
12.6.3 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L):
12.7 Rest of Middle East and Asia Antiviral Drugs Treatment Market Forecast, 2021-2031
12.7.1 Developing Pharmaceutical Industry along with government support
12.7.2 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13 Company Profiles
13.1 Company Share Analysis
13.2 Antiviral Drugs Market Recent Developments, 2017-2020
13.3 AbbVie Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2019
13.3.3.2 Product Revenue Shares, 2019
13.3.3.3 Regional Revenue Shares, 2019
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2017-2020
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2019
13.4.3.2 Product Revenue Shares, 2019
13.4.3.3 Regional Revenue Shares, 2019
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2017-2020
13.5 Gilead Sciences, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2015-2019
13.5.3.2 Product Revenue Shares, 2019
13.5.3.3 Regional Revenue Shares, 2019
13.5.4 Product Benchmarking
13.5.5 Recent Developments, 2017-2020
13.6 Boehringer Ingelheim International GmbH
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2015-2019
13.6.3.2 Product Revenue Shares, 2019
13.6.3.3 Regional Revenue Shares, 2019
13.6.4 Product Benchmarking
13.6.5 Recent Developments, 2017-2020
13.7 AstraZeneca
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2015-2019
13.7.3.2 Product Revenue Shares, 2019
13.7.3.3 Regional Revenue Shares, 2019
13.7.4 Product Benchmarking
13.7.5 Recent Developments, 2017-2020
13.8 GlaxoSmithKline plc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2015-2019
13.8.3.2 Product Revenue Shares, 2019
13.8.3.3 Regional Revenue Shares, 2019
13.8.4 Product Benchmarking
13.8.5 Recent Developments, 2017-2020
13.9 Novartis AG
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2015-2019
13.9.3.2 Product Revenue Shares, 2019
13.9.3.3 Regional Revenue Shares, 2019
13.9.4 Product Benchmarking
13.9.5 Recent Developments, 2017-2020
13.10 Merck & Co., Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2015-2019
13.10.3.2 Product Revenue Shares, 2019
13.10.3.3 Regional Revenue Shares, 2019
13.10.4 Product Benchmarking
13.10.5 Recent Developments, 2017-2020
13.11 Bristol-Myers Squibb Company
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2015-2019
13.11.3.2 Regional Revenue Shares, 2019
13.11.4 Product Benchmarking
13.11.5 Recent Developments, 2017-2020
13.12 Johnson & Johnson Services, Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2015-2019
13.12.3.2 Product Revenue Shares, 2019
13.12.3.3 Regional Revenue Shares, 2019
13.12.4 Product Benchmarking
13.12.5 Recent Developments, 2017-2020
13.13 Cipla Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2015-2019
13.13.3.2 Regional Revenue Shares, 2019
13.13.4 Product Benchmarking
13.13.5 Recent Developments, 2017-2020
13.14 Abbott.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2015-2019
13.14.3.2 Product Revenue Shares, 2019
13.14.3.3 Regional Revenue Shares, 2019
13.14.4 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Global Antiviral Drugs Treatment Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 3 Commonly used DNA Polymerase Inhibitors
Table 4 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 5 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 10 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Commonly used DNA Polymerase Inhibitors
Table 15 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 16 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 17 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 20 Commonly used Neuraminidase Inhibitor’s
Table 21 Global Antiviral Drugs Treatment Market for Neuraminidase Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 22 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 26 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 27 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 32 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 33 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 34 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 37 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 38 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 39 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 40 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 41 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 42 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 43 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 44 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 45 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 46 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 47 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 48 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 49 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 50 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 51 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 52 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 53 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 54 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 55 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 56 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 57 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 58 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 59 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 60 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 61 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 62 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 63 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 64 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 65 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 66 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 67 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 68 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 69 Global Antiviral Drugs Treatment Market for Others Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 70 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 71 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 72 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 73 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 74 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 75 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 76 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 77 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 78 North America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 79 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 80 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 85 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 90 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 95 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 96 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 97 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 98 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 99 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 100 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 101 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 102 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 103 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 104 Europe Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 105 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 106 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 111 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 116 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 117 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 121 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 126 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 131 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 132 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 133 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 134 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 135 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 136 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 141 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 145 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 146 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 147 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 148 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 149 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 150 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 151 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 152 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 153 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 154 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 155 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 156 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 157 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 172 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 177 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 182 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 183 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 184 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 185 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 186 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 187 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 188 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 189 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 190 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 191 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 192 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 193 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 194 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 195 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 196 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 197 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 198 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 199 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 200 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 201 Latin America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 202 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 203 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 208 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 213 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 218 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 223 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 228 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 233 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 234 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 235 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 236 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 237 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 238 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 239 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 240 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 242 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 248 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 249 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 250 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 251 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 252 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 253 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 254 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 255 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 256 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 257 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 258 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 259 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 260 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 261 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 262 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 263 Antiviral Drugs Market Recent Developments, 2017-2020
Table 264 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 265 AbbVie Inc.: Product Benchmarking
Table 266 AbbVie Inc.: Recent Developments, 2017-2020
Table 267 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 268 F. Hoffmann-La Roche Ltd. .: Product Benchmarking
Table 269 F. Hoffmann –La Roche Ltd. : Recent Developments, 2017-2020
Table 270 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Gilead Sciences, Inc. Product Benchmarking
Table 272 Gilead Sciences Inc. Recent Developments, 2017-2020
Table 273 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 275 Boehringer Ingelheim International GmbH; Recent Developments, 2017-2020
Table 276 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 AstraZeneca; Product Benchmarking
Table 278 AstraZeneca Recent Developments, 2017-2020
Table 279 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 GlaxoSmithKline plc.; Product Benchmarking
Table 281 GlaxoSmithKline plc.: Recent Developments, 2017-2020
Table 282 Novartis AG : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 283 Novartis AG: Product Benchmarking
Table 284 Novartis AG: Recent Developments, 2017-2020
Table 285 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 286 Merck & Co., Inc.: Product Benchmarking
Table 287 Merck & Co., Inc.: Recent Developments, 2017-2020
Table 288 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Bristol-Myers Squibb Company: Product Benchmarking
Table 290 Bristol-Myers Squibb Company: Recent Developments, 2017-2020
Table 291 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 293 Johnson & Johnson Services, Inc.: Recent Developments, 2017-2020
Table 294 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Cipla Inc.: Product Benchmarking
Table 296 Cipla Inc.: Recent Developments, 2017-2020
Table 297 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Abbott: Product Benchmarking
List of Figures
Figure 1 Global Anti-Viral Drugs Market Size Forecast 2021-2031 (US$Bn, AGR %)
Figure 2 Global Antiviral Drugs Treatment Market Segmentation
Figure 3 Global Antiviral Drugs Treatment Market: Market Trends
Figure 4 Global Antiviral Drugs Treatment Market: Porter’s Five Forces Analysis
Figure 5 Global Antiviral Drugs Treatment Market: PEST Analysis
Figure 6 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
Figure 7 Global Antiviral Drugs Treatment Market Share Forecast by Drug Class, 2021, 2026, 2031 (%)
Figure 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 9 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 14 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR %)
Figure 34 Global Antiviral Drugs Treatment Market Share Forecast by Application, 2021, 2026, 2031 (%)
Figure 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Antiviral Drugs Treatment Market for HIV Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 41 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Antiviral Drugs Treatment Market for Influenza Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 46 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Antiviral Drugs Treatment Market for Herpes Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 51 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 56 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR %)
Figure 61 Global Antiviral Drugs Treatment Market Share Forecast by End User, 2021, 2026, 2031 (%)
Figure 62 Global Antiviral Drugs Treatment Market for Hospital Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 63 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 64 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 65 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 66 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 67 Global Antiviral Drugs Treatment Market for Clinics Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 68 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 73 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 74 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 75 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 76 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 77 Global Antiviral Drugs Treatment Market Forecast by Region 2021-2031 (US$ billion)
Figure 78 Global Antiviral Drugs Treatment Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 79 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 80 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 81 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 82 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 83 North America Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 84 North America Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 85 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 86 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 87 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 88 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 89 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 90 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 91 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 92 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 93 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 94 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 95 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 96 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 97 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 98 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 99 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 100 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 101 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 102 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 103 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 104 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 105 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 106 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 107 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 108 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 109 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 110 Europe Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 111 Europe Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 112 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 113 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 115 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 116 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 117 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 118 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 123 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 128 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 133 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 138 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 143 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 148 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 153 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 158 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 163 Asia Pacific Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 171 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 172 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 173 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 174 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 175 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 176 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 177 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 178 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 179 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 180 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 181 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 182 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 183 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 184 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 185 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 186 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 187 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 188 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 189 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 190 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 191 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 192 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 193 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 194 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 195 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 200 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 205 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 Latin America Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 210 Latin America Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 212 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 213 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 214 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 215 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 216 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 217 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 218 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 219 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 220 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 221 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 222 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 223 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 224 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 225 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 226 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 227 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 228 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 229 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 230 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 231 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 232 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 233 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 234 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 235 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 236 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 237 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 238 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 239 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 240 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 242 Middle East and Africa Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
Figure 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 248 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 249 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 250 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 251 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 252 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 253 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 254 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 255 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 256 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 257 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 258 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 259 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 260 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 261 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 262 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 263 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 264 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 265 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 266 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 267 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 268 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 269 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 270 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 271 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 272 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 273 Global Antiviral Drugs Treatment Market: Company Share Analysis 2019
Figure 274 AbbVie Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 275 AbbVie Inc.: Product Revenue Shares, 2019
Figure 276 AbbVie Inc.: Regional Revenue Shares, 2019
Figure 277 F. Hoffmann – La Roche Ltd.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 278 F. Hoffmann- La Roche Ltd: Product Revenue Shares, 2019
Figure 279 F. Hoffmann- La Roche Ltd: Regional Revenue Shares, 2019
Figure 280 Gilead Sciences, Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 281 Gilead Sciences, Inc.: Product Revenue Shares, 2019
Figure 282 Gilead Sciences, Inc.: Regional Revenue Shares, 2019
Figure 283 Boehringer Ingelheim Internatinal GmbH : Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 284 Boehringer Ingelheim International GmbH Product Revenue Shares, 2019
Figure 285 Boehringer Ingelheim International GmbH: Regional Revenue Shares, 2019
Figure 286 AstraZeneca: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 287 AstraZeneca: Product Revenue Shares, 2019
Figure 288 AstraZeneca: Regional Revenue Shares, 2019
Figure 289 GlaxoSmithKline plc. Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 290 GlaxoSmithKline plc.: Product Revenue Shares, 2019
Figure 291 GlaxoSmithKline plc.: Regional Revenue Shares, 2019
Figure 292 Novartis AG: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 293 Novartis AG: Product Revenue Shares, 2019
Figure 294 Novartis AG: Regional Revenue Shares, 2019
Figure 295 Merck & Co., Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 296 Merck & Co., Inc.: Product Revenue Shares, 2019
Figure 297 Merck & Co., Inc.: Regional Revenue Shares, 2019
Figure 298 Bristol -Myers Squibb Company: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 299 Bristol -Myers Squibb Company: Regional Revenue Shares, 2019
Figure 300 Johnson & Johnson Services Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 301 Johnson & Johnson Services Inc.: Product Revenue Shares, 2019
Figure 302 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2019
Figure 303 Cipla Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 304 Cipla Inc.: Regional Revenue Shares, 2019
Figure 305 Abbott: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 306 Abbott: Product Revenue Shares, 2019
Figure 307 Abbott: Regional Revenue Shares, 2019
Figure 308 Global Antiviral Drugs Treatment Market Share Forecast by Region, 2021, 2026, 2031 (%)
1.1 Introduction to Antiviral Drugs Treatment Market
1.2 Antiviral Drugs Treatment Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Increasing Incidence of Viral Diseases to drive market growth
3.1.2 Increasing Geriatric Population is projected to propel the Demand for Anti-Viral Drugs
3.1.3 Advancement in Anti-Viral Drugs R&D is driving the Market Growth
3.1.4 Rising Strategic Initiatives for Anti-Viral Drugs Market is another Major Factor Propelling the Market Growth
3.2 Restraints
3.2.1 Stringent Regulations Associated with Product Approval Hinders the Market Growth
3.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.3 Rising Prevalent Resistance to Neuraminidase Inhibitors
3.3 Opportunities
3.3.1 Increasing Corona Virus Disease Emerge Need for Anti-Viral Drugs
3.3.2 M&A and Collaboration by the leading Vendors Provide Opportunity to Grow in the Market
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: Moderate
3.4.5 Threat of Substitutes: Moderate
3.5 PEST Analysis
3.5.1 Political Factors Impacting Antiviral Drugs Treatment Market
3.5.2 Economic Factors Impacting Anti-Viral Drugs Market
3.5.3 Social Factors Impacting Anti-Viral Drugs Market
3.5.4 Technological Factors Impacting Anti-Viral Drugs Market
4 Antiviral Drugs Treatment Market by Drug Class Forecast, 2021-2031
4.1 Reverse Transcriptase Inhibitors Segment Market Forecast, 2021-2031
4.1.1 The reverse-transcriptase inhibitors are class of antiretroviral drugs, majorly used to treat HIV infection and Hepatitis B
4.1.2 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.2 Protease Inhibitors Segment Market Forecast, 2021-2031
4.2.1 The Antiretroviral protease inhibitors bind the catalytic site of the HIV protease
4.2.2 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.3 DNA Polymerase Inhibitors Segment Market Forecast, 2021-2031
4.3.1 Inhibiting DNA synthesis is significant therapeutic strategy, widely used to treat the viral infections
4.3.2 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.4 Neuraminidase Transcriptase Inhibitors Segment Market Forecast, 2021-2031
4.4.1 Growing Public awareness, boost in the Research and Development segment swelling interest to support the development of new Antiviral drugs
4.4.2 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.5 Others Segment Market Forecast, 2021-2031
4.5.1 Other Essential Inhibitors
4.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5 Antiviral Drugs Treatment Market by Application Forecast, 2021-2031
5.1 Hepatitis Segment Market Forecast, 2021-2031
5.1.1 Largest Revenue Grossing Segment / Hepatitis C Virus (HCV) is transmitted through infective blood exposure, or by HCV contaminated blood and blood products
5.1.2 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.2 HIV Segment Market Forecast, 2021-2031
5.2.1 HIV needs protease to replicate, which includes atazanavir, darunavir, fosamprenavir, and lopinavir
5.2.2 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.3 Influenza Inhibitors Segment Market Forecast, 2021-2031
5.3.1 The neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir and peramivir) and M2 protein inhibitors are class of antiviral drugs to treat viral infection
5.3.2 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.4 Herpes Segment Market Forecast, 2021-2031
5.4.1 Herpes is caused by Herpes simplex virus (HSV), which develops sores or blisters to form in or around the mouth or genitals
5.4.2 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.5 Others Segment Market Forecast, 2021-2031
5.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Segment Growth
5.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6 Antiviral Drugs Treatment Market by End User Forecast, 2021-2031
6.1 Hospital Segment Market Forecast, 2021-2031
6.1.1 Pandemic emerge the demand for antiviral drugs
6.1.2 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.2 Clinics Segment Market Forecast, 2021-2031
6.2.1 Increasing use of antiviral drugs for primary treatment include hepatitis B, herpes virus and Influenza virus
6.2.2 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast 2021-2031: Recovery Scenarios (V, U, W, L)
6.3 Others Segment Market Forecast, 2021-2031
6.3.1 The Research Institutes Specialize in the Field of Viral Infection
6.3.2 Recovery Scenarios (V, U, W, L)
7 Global Antiviral Drugs Treatment Market Regional Forecast, 2021-2031
7.1 Global Antiviral Drugs Treatment Market by Region Forecast 2021-2031
7.2 Global Antiviral Drugs Treatment Market Forecast by Region: Recovery Scenarios (V, U, W, L)
8 North America Antiviral Drugs Treatment Market, 2021-2031
8.1 Largest Market Share acquired by North America in Global Antiviral Drugs Treatment Market
8.2 North America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
8.3 North America Antiviral Drugs Treatment Market Forecast by Drug Class
8.3.1 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
8.4 North America Antiviral Drugs Treatment Market Forecast by Application
8.4.1 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
8.5 North America Antiviral Drugs Treatment Market Forecast by End User
8.5.1 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
8.6 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031
8.6.1 Growing burden of Viral Diseases such as HIV, Hepatitis and Corona virus
8.6.2 Presence of Highly Developed Healthcare Infrastructure
8.6.3 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
8.7 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031
8.7.1 Growing burden of Viral Diseases and Government support
8.7.2 Benefits of manufacturing and R&D Operations in Canada
8.7.3 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9 Europe Antiviral Drugs Treatment Market, 2021-2031
9.1 Increasing aging population worldwide would have a direct impact on the healthcare systems,
9.2 Europe Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
9.3 Europe Antiviral Drugs Treatment Market Forecast by Drug Class
9.3.1 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
9.4 Europe Antiviral Drugs Treatment Market Forecast by Application
9.4.1 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
9.5 Europe Antiviral Drugs Treatment Market Forecast by End User
9.5.1 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
9.6 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031
9.6.1 Strong Research and Development pipelines coupled with increasing product launches by the major players
9.6.2 Hepatitis A outbreaks in European Region and the Americas
9.6.3 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.7 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031
9.7.1 Growing HIV Infection
9.7.2 Growing ageing population creating challenges
9.7.3 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.8 France Antiviral Drugs Treatment Market Forecast, 2021-2031
9.8.1 Growing old age population
9.8.2 Affordable Healthcare Services with Workforce Flexibility
9.8.3 France Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.9 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031
9.9.1 Growing Pharmaceutical Industry
9.9.2 Italy ranks amongst the countries with the maximum life expectancy worldwide
9.9.3 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.10 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031
9.10.1 Strongest Economy with growing pharmaceutical Industry
9.10.2 Spreading HIV in the country
9.10.3 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.11 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031
9.11.1 Promising Russian Pharmaceutical Industry
9.11.2 Unmet Pharmaceutical Needs
9.11.3 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031
9.12.1 Growing prevalence of viral infections and strategic initiatives by major market players
9.12.2 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10 Asia Pacific Antiviral Drugs Treatment Market, 2021-2031
10.1 Increased funding for HIV in developing countries
10.2 Asia Pacific Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
10.3 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class
10.3.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
10.4 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application
10.4.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
10.5 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User
10.5.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
10.6 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031
10.6.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
10.6.2 Government Initiative
10.6.3 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.7 China Antiviral Drugs Treatment Market Forecast, 2021-2031
10.7.1 Strategic initiatives taken by market Player
10.7.2 Increasing Healthcare Spending
10.7.3 China Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.8 India Antiviral Drugs Treatment Market Forecast, 2021-2031
10.8.1 India has the third largest HIV epidemic in the world
10.8.2 Developing Healthcare Infrastructure
10.8.3 India Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.9 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031
10.9.1 Government Programme Expand Access to Quality Healthcare
10.9.2 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.10 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031
10.10.1 Spreading HIV in South Korea Region
10.10.2 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.11 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031
10.11.1 Growing viral infection in this Region
10.11.2 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11 Latin America Antiviral Drugs Treatment Market, 2021-2031
11.1 Growing Geriatric population as well as growing GDP of this region
11.2 Latin America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
11.3 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class
11.3.1 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
11.4 Latin America Antiviral Drugs Treatment Market Forecast by Application
11.4.1 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 Latin America Antiviral Drugs Treatment Market Forecast by End User
11.5.1 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031
11.6.1 Growing burden of Viral Disease in Brazil
11.6.2 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11.7 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
11.7.1 Growing Pharmaceutical Industry in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
11.8 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031
11.8.1 Evolving Healthcare Infrastructure
11.8.2 Government and Major market player investing in this region
11.8.3 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12 Middle East and Asia Antiviral Drugs Treatment Market, 2021-2031
12.1 Middle East and Africa Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
12.2 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class
12.2.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
12.3 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application
12.3.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User
12.4.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.5 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031
12.5.1 South Africa ranks 3rd of all new HIV Infection in Southern Africa region
12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
12.5.3 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031
12.6.1 Developing Healthcare Industry in this region
12.6.2 Presence of Huge Growth Opportunities
12.6.3 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L):
12.7 Rest of Middle East and Asia Antiviral Drugs Treatment Market Forecast, 2021-2031
12.7.1 Developing Pharmaceutical Industry along with government support
12.7.2 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13 Company Profiles
13.1 Company Share Analysis
13.2 Antiviral Drugs Market Recent Developments, 2017-2020
13.3 AbbVie Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2019
13.3.3.2 Product Revenue Shares, 2019
13.3.3.3 Regional Revenue Shares, 2019
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2017-2020
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2019
13.4.3.2 Product Revenue Shares, 2019
13.4.3.3 Regional Revenue Shares, 2019
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2017-2020
13.5 Gilead Sciences, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2015-2019
13.5.3.2 Product Revenue Shares, 2019
13.5.3.3 Regional Revenue Shares, 2019
13.5.4 Product Benchmarking
13.5.5 Recent Developments, 2017-2020
13.6 Boehringer Ingelheim International GmbH
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2015-2019
13.6.3.2 Product Revenue Shares, 2019
13.6.3.3 Regional Revenue Shares, 2019
13.6.4 Product Benchmarking
13.6.5 Recent Developments, 2017-2020
13.7 AstraZeneca
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2015-2019
13.7.3.2 Product Revenue Shares, 2019
13.7.3.3 Regional Revenue Shares, 2019
13.7.4 Product Benchmarking
13.7.5 Recent Developments, 2017-2020
13.8 GlaxoSmithKline plc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2015-2019
13.8.3.2 Product Revenue Shares, 2019
13.8.3.3 Regional Revenue Shares, 2019
13.8.4 Product Benchmarking
13.8.5 Recent Developments, 2017-2020
13.9 Novartis AG
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2015-2019
13.9.3.2 Product Revenue Shares, 2019
13.9.3.3 Regional Revenue Shares, 2019
13.9.4 Product Benchmarking
13.9.5 Recent Developments, 2017-2020
13.10 Merck & Co., Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2015-2019
13.10.3.2 Product Revenue Shares, 2019
13.10.3.3 Regional Revenue Shares, 2019
13.10.4 Product Benchmarking
13.10.5 Recent Developments, 2017-2020
13.11 Bristol-Myers Squibb Company
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2015-2019
13.11.3.2 Regional Revenue Shares, 2019
13.11.4 Product Benchmarking
13.11.5 Recent Developments, 2017-2020
13.12 Johnson & Johnson Services, Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2015-2019
13.12.3.2 Product Revenue Shares, 2019
13.12.3.3 Regional Revenue Shares, 2019
13.12.4 Product Benchmarking
13.12.5 Recent Developments, 2017-2020
13.13 Cipla Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2015-2019
13.13.3.2 Regional Revenue Shares, 2019
13.13.4 Product Benchmarking
13.13.5 Recent Developments, 2017-2020
13.14 Abbott.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2015-2019
13.14.3.2 Product Revenue Shares, 2019
13.14.3.3 Regional Revenue Shares, 2019
13.14.4 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Global Antiviral Drugs Treatment Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 3 Commonly used DNA Polymerase Inhibitors
Table 4 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 5 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 10 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Commonly used DNA Polymerase Inhibitors
Table 15 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 16 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 17 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 20 Commonly used Neuraminidase Inhibitor’s
Table 21 Global Antiviral Drugs Treatment Market for Neuraminidase Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 22 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 26 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 27 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 32 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 33 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 34 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 37 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 38 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 39 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 40 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 41 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 42 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 43 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 44 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 45 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 46 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 47 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 48 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 49 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 50 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 51 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 52 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 53 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 54 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 55 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 56 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 57 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 58 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 59 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 60 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 61 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 62 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 63 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 64 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 65 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 66 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 67 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 68 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 69 Global Antiviral Drugs Treatment Market for Others Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 70 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 71 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 72 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 73 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 74 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 75 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 76 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 77 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 78 North America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 79 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 80 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 85 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 90 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 95 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 96 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 97 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 98 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 99 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 100 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 101 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 102 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 103 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 104 Europe Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 105 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 106 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 111 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 116 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 117 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 121 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 126 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 131 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 132 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 133 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 134 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 135 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 136 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 141 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 145 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 146 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 147 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 148 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 149 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 150 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 151 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 152 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 153 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 154 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 155 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 156 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 157 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 172 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 177 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 182 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 183 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 184 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 185 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 186 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 187 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 188 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 189 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 190 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 191 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 192 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 193 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 194 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 195 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 196 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 197 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 198 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 199 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 200 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 201 Latin America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 202 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 203 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 208 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 213 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 218 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 223 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 228 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 233 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 234 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 235 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 236 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 237 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 238 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 239 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 240 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 242 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 248 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 249 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 250 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 251 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 252 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 253 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 254 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 255 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 256 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 257 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 258 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 259 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 260 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 261 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 262 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 263 Antiviral Drugs Market Recent Developments, 2017-2020
Table 264 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 265 AbbVie Inc.: Product Benchmarking
Table 266 AbbVie Inc.: Recent Developments, 2017-2020
Table 267 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 268 F. Hoffmann-La Roche Ltd. .: Product Benchmarking
Table 269 F. Hoffmann –La Roche Ltd. : Recent Developments, 2017-2020
Table 270 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Gilead Sciences, Inc. Product Benchmarking
Table 272 Gilead Sciences Inc. Recent Developments, 2017-2020
Table 273 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 275 Boehringer Ingelheim International GmbH; Recent Developments, 2017-2020
Table 276 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 AstraZeneca; Product Benchmarking
Table 278 AstraZeneca Recent Developments, 2017-2020
Table 279 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 GlaxoSmithKline plc.; Product Benchmarking
Table 281 GlaxoSmithKline plc.: Recent Developments, 2017-2020
Table 282 Novartis AG : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 283 Novartis AG: Product Benchmarking
Table 284 Novartis AG: Recent Developments, 2017-2020
Table 285 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 286 Merck & Co., Inc.: Product Benchmarking
Table 287 Merck & Co., Inc.: Recent Developments, 2017-2020
Table 288 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Bristol-Myers Squibb Company: Product Benchmarking
Table 290 Bristol-Myers Squibb Company: Recent Developments, 2017-2020
Table 291 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 293 Johnson & Johnson Services, Inc.: Recent Developments, 2017-2020
Table 294 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Cipla Inc.: Product Benchmarking
Table 296 Cipla Inc.: Recent Developments, 2017-2020
Table 297 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Abbott: Product Benchmarking
List of Figures
Figure 1 Global Anti-Viral Drugs Market Size Forecast 2021-2031 (US$Bn, AGR %)
Figure 2 Global Antiviral Drugs Treatment Market Segmentation
Figure 3 Global Antiviral Drugs Treatment Market: Market Trends
Figure 4 Global Antiviral Drugs Treatment Market: Porter’s Five Forces Analysis
Figure 5 Global Antiviral Drugs Treatment Market: PEST Analysis
Figure 6 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
Figure 7 Global Antiviral Drugs Treatment Market Share Forecast by Drug Class, 2021, 2026, 2031 (%)
Figure 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 9 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 14 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR %)
Figure 34 Global Antiviral Drugs Treatment Market Share Forecast by Application, 2021, 2026, 2031 (%)
Figure 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Antiviral Drugs Treatment Market for HIV Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 41 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Antiviral Drugs Treatment Market for Influenza Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 46 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Antiviral Drugs Treatment Market for Herpes Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 51 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 56 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR %)
Figure 61 Global Antiviral Drugs Treatment Market Share Forecast by End User, 2021, 2026, 2031 (%)
Figure 62 Global Antiviral Drugs Treatment Market for Hospital Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 63 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 64 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 65 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 66 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 67 Global Antiviral Drugs Treatment Market for Clinics Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 68 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 73 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 74 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 75 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 76 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 77 Global Antiviral Drugs Treatment Market Forecast by Region 2021-2031 (US$ billion)
Figure 78 Global Antiviral Drugs Treatment Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 79 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 80 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 81 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 82 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 83 North America Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 84 North America Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 85 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 86 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 87 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 88 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 89 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 90 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 91 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 92 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 93 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 94 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 95 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 96 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 97 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 98 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 99 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 100 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 101 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 102 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 103 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 104 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 105 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 106 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 107 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 108 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 109 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 110 Europe Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 111 Europe Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 112 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 113 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 115 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 116 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 117 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 118 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 123 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 128 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 133 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 138 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 143 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 148 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 153 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 158 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 163 Asia Pacific Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 171 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 172 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 173 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 174 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 175 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 176 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 177 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 178 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 179 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 180 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 181 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 182 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 183 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 184 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 185 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 186 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 187 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 188 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 189 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 190 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 191 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 192 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 193 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 194 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 195 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 200 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 205 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 Latin America Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 210 Latin America Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
Figure 212 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 213 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 214 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 215 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 216 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 217 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 218 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 219 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 220 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 221 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 222 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 223 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 224 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 225 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 226 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 227 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 228 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 229 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 230 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 231 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 232 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 233 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 234 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 235 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 236 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 237 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 238 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 239 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 240 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
Figure 242 Middle East and Africa Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
Figure 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 248 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
Figure 249 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 250 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 251 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 252 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 253 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
Figure 254 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 255 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 256 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 257 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 258 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 259 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 260 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 261 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 262 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 263 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 264 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 265 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 266 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 267 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 268 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 269 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 270 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 271 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 272 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 273 Global Antiviral Drugs Treatment Market: Company Share Analysis 2019
Figure 274 AbbVie Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 275 AbbVie Inc.: Product Revenue Shares, 2019
Figure 276 AbbVie Inc.: Regional Revenue Shares, 2019
Figure 277 F. Hoffmann – La Roche Ltd.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 278 F. Hoffmann- La Roche Ltd: Product Revenue Shares, 2019
Figure 279 F. Hoffmann- La Roche Ltd: Regional Revenue Shares, 2019
Figure 280 Gilead Sciences, Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 281 Gilead Sciences, Inc.: Product Revenue Shares, 2019
Figure 282 Gilead Sciences, Inc.: Regional Revenue Shares, 2019
Figure 283 Boehringer Ingelheim Internatinal GmbH : Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 284 Boehringer Ingelheim International GmbH Product Revenue Shares, 2019
Figure 285 Boehringer Ingelheim International GmbH: Regional Revenue Shares, 2019
Figure 286 AstraZeneca: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 287 AstraZeneca: Product Revenue Shares, 2019
Figure 288 AstraZeneca: Regional Revenue Shares, 2019
Figure 289 GlaxoSmithKline plc. Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 290 GlaxoSmithKline plc.: Product Revenue Shares, 2019
Figure 291 GlaxoSmithKline plc.: Regional Revenue Shares, 2019
Figure 292 Novartis AG: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 293 Novartis AG: Product Revenue Shares, 2019
Figure 294 Novartis AG: Regional Revenue Shares, 2019
Figure 295 Merck & Co., Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 296 Merck & Co., Inc.: Product Revenue Shares, 2019
Figure 297 Merck & Co., Inc.: Regional Revenue Shares, 2019
Figure 298 Bristol -Myers Squibb Company: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 299 Bristol -Myers Squibb Company: Regional Revenue Shares, 2019
Figure 300 Johnson & Johnson Services Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 301 Johnson & Johnson Services Inc.: Product Revenue Shares, 2019
Figure 302 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2019
Figure 303 Cipla Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 304 Cipla Inc.: Regional Revenue Shares, 2019
Figure 305 Abbott: Net Revenue, 2015-2019 (US$ billion, AGR%)
Figure 306 Abbott: Product Revenue Shares, 2019
Figure 307 Abbott: Regional Revenue Shares, 2019
Figure 308 Global Antiviral Drugs Treatment Market Share Forecast by Region, 2021, 2026, 2031 (%)
Companies Profiled in the Report
Abbott Laboratories
AbbVie
AstraZeneca AB,
Boehringer Ingelheim Corporation
Bristol-Myers-Squibb,
Cipla Inc.
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc.
GlaxoSmithKline,
Johnson & Johnson
Merck & Co
Novartis AG
List of Companies Mentioned in the Report
Abbott Laboratories
AbbVie
Alexion Pharmaceuticals
Allergan
Alvotech
Amblyotech
ArQule, Inc.
Astex Pharmaceuticals
AstraZeneca AB,
Atea Pharmaceuticals, Inc.
Auris Health, Inc.
Aurobindo Pharma
Blueprint Medicines Corporation
Boehringer Ingelheim Corporation
Bristol-Myers-Squibb,
Cadent Therapeutics
Catalent Inc.
Cipla Inc.
Coalition for Epidemic Preparedness Innovations
Daiichi Sankyo
DR. CI:LABO
Dr. Reddy’s Laboratories Ltd.
F. Hoffmann-La Roche Ltd
Forbius
Forty Seven, Inc.
Gedeon Richter Plc.
Gilead Sciences Inc.
GlaxoSmithKline,
Gritstone Oncology
Immunomedics, Inc.
Inflazome
Johnson & Johnson
Merck & Co
MyoKardia
MYR GmbH
NBE-Therapeutics
Northern Biologics Inc.
Novartis
Novartis AG
OncoImmune
Otsuka Pharmaceutical Co., Ltd.
Pandion Therapeutics, Inc.
Premier Medical Corporation
Samsung Biologics
SHIONOGI Co., Ltd.
Spark Therapeutics, Inc.
Stratos Genomics
Taiho Pharmaceutical Co, Ltd.
The Medicines Company
Themis
Vedere Bio
VelosBio Inc
Verb Surgical Inc.
Vir Biotechnology, Inc.
Wanbury Ltd.
XBiotech Inc.
List of Organizations Mentioned in the Report
Abbreviated New Drug Application (ANDA)
CDER (Center for Drug Evaluation and Research)
Centers for Disease Control and Prevention (CDC)
ClinicalTrials.gov
European Commission
Food and Drug Administration (FDA)
Gates Foundation
Government of Japan
Korea Centers for Disease Control
Minister of Health of the Democratic Republic of the Congo
National Development and Reform Commission (NDRC)
National Health Service (NHS)
National Institute of Health (NIH)
National Institute of Statistics and geography (INEGI)
NCBI
Pan American Health Organization (PAHO)
United Nations Programme on HIV/AIDS
US Securities and Exchange Commission
USFDA (United States Food and Drug Administration)
WHO (World Health Organization)
World Population Prospects
Abbott Laboratories
AbbVie
AstraZeneca AB,
Boehringer Ingelheim Corporation
Bristol-Myers-Squibb,
Cipla Inc.
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc.
GlaxoSmithKline,
Johnson & Johnson
Merck & Co
Novartis AG
List of Companies Mentioned in the Report
Abbott Laboratories
AbbVie
Alexion Pharmaceuticals
Allergan
Alvotech
Amblyotech
ArQule, Inc.
Astex Pharmaceuticals
AstraZeneca AB,
Atea Pharmaceuticals, Inc.
Auris Health, Inc.
Aurobindo Pharma
Blueprint Medicines Corporation
Boehringer Ingelheim Corporation
Bristol-Myers-Squibb,
Cadent Therapeutics
Catalent Inc.
Cipla Inc.
Coalition for Epidemic Preparedness Innovations
Daiichi Sankyo
DR. CI:LABO
Dr. Reddy’s Laboratories Ltd.
F. Hoffmann-La Roche Ltd
Forbius
Forty Seven, Inc.
Gedeon Richter Plc.
Gilead Sciences Inc.
GlaxoSmithKline,
Gritstone Oncology
Immunomedics, Inc.
Inflazome
Johnson & Johnson
Merck & Co
MyoKardia
MYR GmbH
NBE-Therapeutics
Northern Biologics Inc.
Novartis
Novartis AG
OncoImmune
Otsuka Pharmaceutical Co., Ltd.
Pandion Therapeutics, Inc.
Premier Medical Corporation
Samsung Biologics
SHIONOGI Co., Ltd.
Spark Therapeutics, Inc.
Stratos Genomics
Taiho Pharmaceutical Co, Ltd.
The Medicines Company
Themis
Vedere Bio
VelosBio Inc
Verb Surgical Inc.
Vir Biotechnology, Inc.
Wanbury Ltd.
XBiotech Inc.
List of Organizations Mentioned in the Report
Abbreviated New Drug Application (ANDA)
CDER (Center for Drug Evaluation and Research)
Centers for Disease Control and Prevention (CDC)
ClinicalTrials.gov
European Commission
Food and Drug Administration (FDA)
Gates Foundation
Government of Japan
Korea Centers for Disease Control
Minister of Health of the Democratic Republic of the Congo
National Development and Reform Commission (NDRC)
National Health Service (NHS)
National Institute of Health (NIH)
National Institute of Statistics and geography (INEGI)
NCBI
Pan American Health Organization (PAHO)
United Nations Programme on HIV/AIDS
US Securities and Exchange Commission
USFDA (United States Food and Drug Administration)
WHO (World Health Organization)
World Population Prospects
Download sample pages
Complete the form below to download your free sample pages for Antiviral Drugs Treatment Market Report 2021-2031Related reports
-
Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power,...Full DetailsPublished: 31 March 2021 -
Antibiotics Market Report 2023-2033
The global Antibiotics market is projected to grow at a CAGR of 4.15% by 2033...Full DetailsPublished: 31 January 2023 -
Aortic Aneurysm Market Report 2021-2031
The growth in the market can be attributed to the high tobacco smoking prevalence in the developed and developing region,...Full DetailsPublished: 21 April 2021 -
Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031
Over the last few years, the antisense oligonucleotide therapeutics has gained widespread attention due to the technological advancements and growth...Full DetailsPublished: 17 March 2021 -
Antibiotics Market Report 2021-2031
The rising prevalence of tuberculosis, malaria, pneumonia, bacterial skin infections, HIV/AIDS, urinary tract infections (UTI), and other diseases will support...Full DetailsPublished: 15 April 2021 -
Drug Discovery Outsourcing Market Report 2020-2030
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug...
Full DetailsPublished: 24 August 2020 -
Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2020-2030
Overall world revenue for Cancer Immunotherapy Drug Discovery Outsourcing will surpass $750 million in 2020, our work calculates. We predict...
Full DetailsPublished: 01 January 1970 -
Pulmonary/Respiratory Drug Delivery Market Report 2020-2030
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years,...Full DetailsPublished: 30 September 2020 -
Oligonucleotide Synthesis Market Forecast 2020-2030
The oligonucleotide synthesis demand has increased as a result of increased government spending, research and development expenses on pharmaceutical and...
Full DetailsPublished: 01 January 1970 -
Hospital Acquired Infection Treatment Market Report 2021-2031
Where the Hospital Acquired Infection Treatment is market heading? If you are involved in this sector you must read this...Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Antiviral Drugs Treatment Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.
11 April 2024
